Microphysiological systems (MPS) are advanced in vitro platforms engineered to replicate in vivo conditions for studying human biology, disease mechanisms, and drug responses with greater physiological relevance. Fluorescence sensing is widely used as a functional readout in MPS due to its high sensitivity, selectivity, and stability. However, conventional fluorescence sensing systems often rely on bulky instrumentation with limited integration, which restricts continuous in situ monitoring, scalable high-throughput analysis, and spatially resolved investigation in multi-organ-on-a-chip models. To address these limitations, we present a highly miniaturized, fully integrated optical system with a 1 mm² footprint, enabling continuous in situ fluorescence monitoring of three-dimensional microtissues in close proximity. The system integrates microscale illumination and sensing units for fluorescence excitation and selective detection, an optical element for guided light propagation, and a microcage for mechanical confinement of microtissues. To demonstrate its capabilities, we integrated the miniaturized optical system with an MPS-relevant platform to monitor fluorescence signals in transgenic mouse pancreatic islets expressing genetically encoded calcium indicators. The integrated platform enables real-time, continuous monitoring of islet responses to potassium chloride stimulation and tracking of calcium oscillations for over two hours, providing valuable information about the functional status of the pancreatic islets. Our work enhances the analytical capabilities of MPS through the integration of miniaturized on-chip quantitative assessment tools, enabling precise, in situ, and continuous monitoring of biological activities in close proximity.

Organic electrochemical transistors (OECTs) are key bioelectronic devices with applications in neuromorphics, sensing, and flexible electronics. OECTs made using biobased and biodegradable materials are emerging as a sustainable alternative to nondegradable plastic and metal-based electronics. Printing is the key technique used to fabricate these types of devices, enabling fabrication at room temperature and using benign solvents, such as water. However, printing techniques suffer from relatively low resolution (tens to hundreds of micrometers), far below the micrometer resolution achieved via conventional metal deposition and photolithography. Here, we present a high-throughput additive-subtractive microfabrication strategy for carbon-based flexible OECTs using biodegradable materials and room-temperature processing. Additive manufacturing of large features is achieved via extrusion printing of a graphene ink to fabricate electrode contacts on cellulose acetate (CA), which serves both as the substrate and as the insulation layer. Combined with femtosecond (fs) laser ablation, this approach enables micrometer-resolution patterning of freestanding OECTs with channel openings down to 1 μm and sheet resistance below 10 Ω/sq. By tuning laser parameters, we demonstrate both selective and simultaneous ablation strategies, enabling the fabrication of horizontal, vertical, and planar-gated OECTs, as well as complementary NOT gate inverters. Thermal degradation studies in air show that over 80% of the device mass decomposes below 360 °C, providing a low-energy route for device disposal and addressing the environmental impact of electronic waste. This approach offers a lithography-free pathway toward the rapid prototyping of high-resolution, sustainable organic electronics, combining circularity, process simplicity, and architectural versatility for next-generation bioelectronic applications. 

Non-destructive imaging techniques are essential for characterising spatiotemporal behaviour of polymer-based drug delivery systems, particularly for evaluating in vitro drug distribution and release kinetics. Here, we present a multimodal in situ imaging approach employing confocal Raman microscopy and fluorescence imaging to investigate methacrylate-based photopolymer microstructure polymerised together with PLGA in the blend, while encapsulating dexamethasone fluorescein as a model drug. Raman spectral analysis confirms both polymer and drug components presence within the composite structure, while hyperspectral Raman imaging provides spatial mapping across the 3D microstructure, capturing both areal and depth-resolved heterogeneity. Furthermore, time-dependent fluorescence imaging offers complementary temporal data on drug localisation and diffusion by tracking real-time water penetration and polymer surface degradation. Fluorescence intensity flux serves as a proxy for drug release kinetics and is further validated through quantitative spectrophotometer analysis. By correlating chemical specific information from Raman microscopy with dynamic visualisation from fluorescence imaging, this approach enables comprehensive in situ monitoring of biophysical properties under simulated physiological conditions without compromising the microstructural integrity or disrupting the experimental environment.